BIOSCIENCE NEUTRACEUTICALS, INC. Interest Income (Expense), Net
BIOSCIENCE NEUTRACEUTICALS, INC. reported Interest Income (Expense), Net of -$166.30 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-30.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNet · last filed 2020-03-30
- BIOSCIENCE NEUTRACEUTICALS, INC. interest income (expense), net for the quarter ending 2019-12-31 was -$149.61K.
- BIOSCIENCE NEUTRACEUTICALS, INC. interest income (expense), net for the quarter ending 2019-09-30 was -$5.28K.
- BIOSCIENCE NEUTRACEUTICALS, INC. interest income (expense), net for the quarter ending 2019-06-30 was -$5.22K.
- BIOSCIENCE NEUTRACEUTICALS, INC. interest income (expense), net for the quarter ending 2019-03-31 was -$6.18K.
- BIOSCIENCE NEUTRACEUTICALS, INC. interest income (expense), net for fiscal 2019 was -$166.30K.
- BIOSCIENCE NEUTRACEUTICALS, INC. interest income (expense), net for fiscal 2018 was -$24.95K.
- BIOSCIENCE NEUTRACEUTICALS, INC. interest income (expense), net for fiscal 2017 was -$28.14K.
| Period end | Interest Income (Expense), Net 3 month | Interest Income (Expense), Net 6 month | Interest Income (Expense), Net 9 month | Interest Income (Expense), Net 12 month |
|---|---|---|---|---|
| 2019-12-31 | -$149.61K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | -$154.89K derived: sum of 2 quarters · filed 2020-03-30 | -$160.12K derived: sum of 3 quarters · filed 2020-03-30 | -$166.30K 10-K · filed 2020-03-30 |
| 2019-09-30 | -$5.28K 10-Q · filed 2019-11-12 | -$10.51K derived: sum of 2 quarters · filed 2019-11-12 | -$16.68K 10-Q · filed 2019-11-12 | -$23.11K derived: sum of 4 quarters · filed 2020-03-30 |
| 2019-06-30 | -$5.22K 10-Q · filed 2019-08-12 | -$11.40K 10-Q · filed 2019-08-12 | -$17.83K derived: sum of 3 quarters · filed 2020-03-30 | -$24.26K derived: sum of 4 quarters · filed 2020-03-30 |
| 2019-03-31 | -$6.18K 10-Q · filed 2019-05-15 | -$12.61K derived: sum of 2 quarters · filed 2020-03-30 | -$19.04K derived: sum of 3 quarters · filed 2020-03-30 | -$25.40K derived: sum of 4 quarters · filed 2020-03-30 |
| 2018-12-31 | -$6.43K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | -$12.86K derived: sum of 2 quarters · filed 2020-03-30 | -$19.22K derived: sum of 3 quarters · filed 2020-03-30 | -$24.95K 10-K · filed 2020-03-30 |
| 2018-09-30 | -$6.43K 10-Q · filed 2019-11-12 | -$12.79K derived: sum of 2 quarters · filed 2019-11-12 | -$18.52K 10-Q · filed 2019-11-12 | -$44.21K derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | -$6.36K 10-Q · filed 2019-08-12 | -$12.10K 10-Q · filed 2019-08-12 | -$37.78K derived: sum of 3 quarters · filed 2019-08-12 | -$40.24K derived: sum of 4 quarters · filed 2019-08-12 |
| 2018-03-31 | -$5.73K 10-Q · filed 2019-05-15 | -$31.41K derived: sum of 2 quarters · filed 2019-05-15 | -$33.88K derived: sum of 3 quarters · filed 2019-05-15 | |
| 2017-12-31 | -$25.68K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-09 | -$28.14K derived: sum of 2 quarters · filed 2019-04-09 | -$28.14K 10-K · filed 2019-04-09 | |
| 2017-09-30 | -$2.46K 10-Q · filed 2019-01-09 | -$2.46K 10-Q · filed 2019-01-09 |